ABS.OL
Price:
$3.87
Market Cap:
$103.95M
Arctic Bioscience AS, a biotechnology company, develops and commercializes pharmaceutical and nutraceutical products. Its development stage product candidate is HRO350, a novel oral treatment for mild-to-moderate psoriasis. The company sells its nutraceuticals as bulk ingredients to other companies under the ROMEGA brand worldwide. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.
Industry
Biotechnology
IPO Date
2021-02-24
Stock Exchange
OSL
Ticker
ABS.OL
According to Arctic Bioscience AS’s latest financial reports and current stock price. The company's current Enterprise Value is 156.62M. This represents a change of -4.68% compared to the average of 164.31M of the last 4 quarters.
The mean historical Enterprise Value of Arctic Bioscience AS over the last ten years is 373.83M. The current 156.62M Enterprise Value has changed 4.09% with respect to the historical average. Over the past ten years (40 quarters), ABS.OL's Enterprise Value was at its highest in in the June 2024 quarter at 241.62M. The Enterprise Value was at its lowest in in the June 2021 quarter at -242401776.00.
Average
373.83M
Median
207.40M
Minimum
77.25M
Maximum
679.93M
Discovering the peaks and valleys of Arctic Bioscience AS Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 30.13%
Maximum Annual Enterprise Value = 679.93M
Minimum Annual Increase = -68.82%
Minimum Annual Enterprise Value = 77.25M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 77.25M | -59.22% |
| 2023 | 189.43M | 30.13% |
| 2022 | 145.57M | -29.81% |
| 2021 | 207.40M | -68.82% |
| 2020 | 665.27M | 2.04% |
| 2019 | 651.98M | -4.11% |
The current Enterprise Value of Arctic Bioscience AS (ABS.OL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
137.42M
5-year avg
256.98M
10-year avg
373.83M
Arctic Bioscience AS’s Enterprise Value is greater than Airthings ASA (4.82M), greater than BerGenBio ASA (-20176449.00), less than Huddly AS (421.18M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 4.82M | $38.59M | |
| -20176449.00 | $45.74M | |
| 421.18M | $342.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arctic Bioscience AS using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arctic Bioscience AS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Arctic Bioscience AS's Enterprise Value?
What is the highest Enterprise Value for Arctic Bioscience AS (ABS.OL)?
What is the 3-year average Enterprise Value for Arctic Bioscience AS (ABS.OL)?
What is the 5-year average Enterprise Value for Arctic Bioscience AS (ABS.OL)?
How does the current Enterprise Value for Arctic Bioscience AS (ABS.OL) compare to its historical average?